Regencell Bioscience
3 hedge funds and large institutions have $171K invested in Regencell Bioscience in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$169K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $169K | +$169K | +610,014 | New |
|
2
BlackRock
New York
| $2.5K | – | – | – |
|
3
Qube Research & Technologies (QRT)
London,
United Kingdom
| $122 | – | – | – |
|
|
4
Morgan Stanley
New York
| – | -$4.56K | -12,388 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$1.19K | -3,230 | Closed |
|